Acute Investment Advisory’s iShares Core Dividend Growth ETF DGRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
3,165
-152
-5% -$11.2K 2.54% 17
2026
Q1
$233K Buy
3,317
+334
+11% +$23.9K 2.61% 17
2025
Q4
$207K Sell
2,983
-466
-14% -$32K 2.01% 15
2025
Q3
$235K Sell
3,449
-808
-19% -$53.4K 1.97% 17
2025
Q2
$272K Buy
+4,257
New +$260K 2.22% 16
2022
Q2
Sell
-68,444
Closed -$3.66M 31
2022
Q1
$3.66M Buy
+68,444
New +$3.65M 2.73% 14

Other funds holding DGRO

Acute Investment Advisory's DGRO Position: Q2 2026 in Review

Acute Investment Advisory reduced its iShares Core Dividend Growth ETF (DGRO) stake by 4.6% in Q2 2026, selling an estimated $11.2K and leaving 3,165 shares worth $240K. The position accounts for 2.54% of the portfolio, ranked #17.

Acute Investment Advisory first reported a position in DGRO in Q1 2022 and has held it in 6 quarters since. The position peaked at $3.66M in Q1 2022. 751 funds tracked by Wall St. Rank hold DGRO as of Q2 2026.

  • Acute Investment Advisory held 3,165 shares of iShares Core Dividend Growth ETF worth $240K as of Q2 2026.
  • Acute Investment Advisory sold 152 iShares Core Dividend Growth ETF shares in Q2 2026, an estimated $11.2K.
  • iShares Core Dividend Growth ETF made up 2.54% of Acute Investment Advisory's portfolio in Q2 2026, its #17 holding.
  • Acute Investment Advisory first reported a position in iShares Core Dividend Growth ETF in Q1 2022 and has held it in 6 quarters since.
  • Acute Investment Advisory's iShares Core Dividend Growth ETF position peaked at $3.66M in Q1 2022.
  • 751 funds tracked by Wall St. Rank held iShares Core Dividend Growth ETF as of Q2 2026.

Based on Acute Investment Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.